Polymorphism of Transcription Factor-7-Like 2 (TCF7L2) Gene and New-Onset Diabetes after Liver Transplantation

• Main Authors: Z Musavi, N Azarpira, MH Sangtarash, M Kordi, K Kazemi, B Geramizadeh, SA Malek-Hosseini
• Format: Article
• Language: English
• Published: Shiraz University of Medical Sciences 2015-01-01
• Series: International Journal of Organ Transplantation Medicine
• Subjects: Transcription factor 7-like 2 protein; Diabetes mellitus; Polymorphism, genetic; Liver transplantation; Transcription factors
• Online Access: http://www.ijotm.com/ojs/index.php/IJOTM/article/view/219

Background: New-onset diabetes after transplantation (NODAT) is a serious complication in transplant recipients. Transcription factor-7-like 2 (TCF7L2) is a Wnt signaling-associated transcription factor that plays an important role in β-cell proliferation and insulin secretion. The association between TCF7L2 SNP rs7903146 and NODAT was documented in renal transplant patients. Objective: To determine the association between TCF7L2 rs7903146 variants and the risk of NODAT after liver transplantation. Methods: This study was conducted on 140 liver transplant recipients who had received tacrolimusbased immunosuppressive drugs. The patients were divided into NODAT (n=70) and non-NODAT (n=70) groups and were genotyped using PCR-RFLP. In addition, 100 normal subjects were considered as the comparison group. Results: There was a significant difference (p<0.05) between the two study groups regarding donor and recipient age, recipient body mass index, and recipient fasting plasma glucose before the transplantation. No significant relationship was observed between TCF7L2 rs7903146 genotypes and development of NODAT. No significant difference was also found between the two groups in terms of the tacrolimus and mycophenolate mofetil daily dosage as well as tacrolimus blood level. However, the prednisolone daily dosage was significantly (p=0.01) higher in the NODAT group compared to those without NODAT. The majority of the patients in the NODAT group also had an episode of acute rejection. Furthermore, a significant difference was found between the transplant recipients and the comparison subjects regarding T allele (p<0.001, OR=1.96) and TT genotype (p<0.001, OR=3.47) frequencies. Conclusion: No correlation was found between TCF7L2 genotypes and development of NODAT. Acute rejection and prednisolone pulse therapy predisposed the susceptible patients to NODAT.